Selected research
Industry Growth & Trends
Global Anthranilamide Industry Growth and Trends Forecast to 2032
Market perspective
The global Anthranilamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Anthranilamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Anthranilamide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anthranilamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anthranilamide include Alchemo Industries, Biosynth, Kavya Pharma and Sarex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Anthranilamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Anthranilamide market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anthranilamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anthranilamide.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Anthranilamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Anthranilamide Market by Company
Alchemo Industries
Biosynth
Kavya Pharma
Sarex
Anthranilamide Segment by Type
0.99
0.98
Anthranilamide Segment by Application
Medicine
Spices
Pesticide
Chemical
Others
Anthranilamide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anthranilamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anthranilamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anthranilamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anthranilamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Anthranilamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.99
- 0.98
Applications
- Medicine
- Spices
- Pesticide
- Chemical
- Others
Companies covered
- Alchemo Industries
- Biosynth
- Kavya Pharma
- Sarex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Anthranilamide Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Anthranilamide Sales Estimates and Forecasts (2021-2032)
- 1.3 Anthranilamide Market by Type
- 1.3.1 0.99
- 1.3.2 0.98
- 1.4 Global Anthranilamide Market Size by Type
- 1.4.1 Global Anthranilamide Market Size Overview by Type (2021-2032)
- 1.4.2 Global Anthranilamide Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Anthranilamide Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Anthranilamide Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Anthranilamide Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Anthranilamide Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Anthranilamide Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Anthranilamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Anthranilamide Industry Trends
- 2.2 Anthranilamide Industry Drivers
- 2.3 Anthranilamide Industry Opportunities and Challenges
- 2.4 Anthranilamide Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Anthranilamide Revenue (2021-2026)
- 3.2 Global Top Players by Anthranilamide Sales (2021-2026)
- 3.3 Global Top Players by Anthranilamide Price (2021-2026)
- 3.4 Global Anthranilamide Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anthranilamide Major Company Production Sites & Headquarters
- 3.6 Global Anthranilamide Company, Product Type & Application
- 3.7 Global Anthranilamide Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anthranilamide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anthranilamide Players Market Share by Revenue in 2025
- 3.8.3 2025 Anthranilamide Tier 1, Tier 2, and Tier 3
4 Anthranilamide Regional Status and Outlook
- 4.1 Global Anthranilamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Anthranilamide Historic Market Size by Region
- 4.2.1 Global Anthranilamide Sales in Volume by Region (2021-2026)
- 4.2.2 Global Anthranilamide Sales in Value by Region (2021-2026)
- 4.2.3 Global Anthranilamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Anthranilamide Forecasted Market Size by Region
- 4.3.1 Global Anthranilamide Sales in Volume by Region (2027-2032)
- 4.3.2 Global Anthranilamide Sales in Value by Region (2027-2032)
- 4.3.3 Global Anthranilamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anthranilamide by Application
- 5.1 Anthranilamide Market by Application
- 5.1.1 Medicine
- 5.1.2 Spices
- 5.1.3 Pesticide
- 5.1.4 Chemical
- 5.1.5 Others
- 5.2 Global Anthranilamide Market Size by Application
- 5.2.1 Global Anthranilamide Market Size Overview by Application (2021-2032)
- 5.2.2 Global Anthranilamide Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Anthranilamide Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Anthranilamide Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Anthranilamide Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Anthranilamide Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Anthranilamide Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Anthranilamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Alchemo Industries
- 6.1.1 Alchemo Industries Company Information
- 6.1.2 Alchemo Industries Business Overview
- 6.1.3 Alchemo Industries Anthranilamide Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Alchemo Industries Anthranilamide Product Portfolio
- 6.1.5 Alchemo Industries Recent Developments
- 6.2 Biosynth
- 6.2.1 Biosynth Company Information
- 6.2.2 Biosynth Business Overview
- 6.2.3 Biosynth Anthranilamide Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Biosynth Anthranilamide Product Portfolio
- 6.2.5 Biosynth Recent Developments
- 6.3 Kavya Pharma
- 6.3.1 Kavya Pharma Company Information
- 6.3.2 Kavya Pharma Business Overview
- 6.3.3 Kavya Pharma Anthranilamide Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Kavya Pharma Anthranilamide Product Portfolio
- 6.3.5 Kavya Pharma Recent Developments
- 6.4 Sarex
- 6.4.1 Sarex Company Information
- 6.4.2 Sarex Business Overview
- 6.4.3 Sarex Anthranilamide Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sarex Anthranilamide Product Portfolio
- 6.4.5 Sarex Recent Developments
7 North America by Country
- 7.1 North America Anthranilamide Sales by Country
- 7.1.1 North America Anthranilamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Anthranilamide Sales by Country (2021-2026)
- 7.1.3 North America Anthranilamide Sales Forecast by Country (2027-2032)
- 7.2 North America Anthranilamide Market Size by Country
- 7.2.1 North America Anthranilamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Anthranilamide Market Size by Country (2021-2026)
- 7.2.3 North America Anthranilamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Anthranilamide Sales by Country
- 8.1.1 Europe Anthranilamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Anthranilamide Sales by Country (2021-2026)
- 8.1.3 Europe Anthranilamide Sales Forecast by Country (2027-2032)
- 8.2 Europe Anthranilamide Market Size by Country
- 8.2.1 Europe Anthranilamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Anthranilamide Market Size by Country (2021-2026)
- 8.2.3 Europe Anthranilamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Anthranilamide Sales by Country
- 9.1.1 Asia-Pacific Anthranilamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Anthranilamide Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Anthranilamide Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Anthranilamide Market Size by Country
- 9.2.1 Asia-Pacific Anthranilamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Anthranilamide Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Anthranilamide Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Anthranilamide Sales by Country
- 10.1.1 South America Anthranilamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Anthranilamide Sales by Country (2021-2026)
- 10.1.3 South America Anthranilamide Sales Forecast by Country (2027-2032)
- 10.2 South America Anthranilamide Market Size by Country
- 10.2.1 South America Anthranilamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Anthranilamide Market Size by Country (2021-2026)
- 10.2.3 South America Anthranilamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Anthranilamide Sales by Country
- 11.1.1 Middle East and Africa Anthranilamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Anthranilamide Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Anthranilamide Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Anthranilamide Market Size by Country
- 11.2.1 Middle East and Africa Anthranilamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Anthranilamide Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Anthranilamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Anthranilamide Value Chain Analysis
- 12.1.1 Anthranilamide Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Anthranilamide Production Mode & Process
- 12.2 Anthranilamide Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Anthranilamide Distributors
- 12.2.3 Anthranilamide Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst